
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES208
This study was terminated early (3.7 years) and in the diabetic subgroup there were no significant
changes identified with aspirin in incidence of major CV and cerebrovascular events. Level 1+

[@2001]

